Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
{{output}}
Background: Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different fo... ...
